Most Active Stories
- Historic Ice-Out Of Winnipesaukee Expected
- Newbie Urban Gardeners Don't Realize How Much Soil Is Contaminated
- Mariano Rivera Jr. To Play For Laconia Muskrats This Summer
- New N.H. Housing Report: Demographics & Housing Mismatch
- A Glimpse At Your Future Electric Bill? N.H. Utility Experiments Encourage Conservation
Wed November 27, 2013
Family Of 12-Year-Old Hudson Girl Seeks FDA Exception For Cancer Drug
U.S. Senator Kelly Ayotte is reaching out to the Food and Drug Administration in an effort to help a Hudson girl with a rare form of brain cancer.
The family of McKenzie Lowe is seeking permission to use an experimental treatment currently banned by the FDA.
In a letter sent this week, Senator Kelly Ayotte urged FDA Commissioner Margaret Hamburg to grant an exception for McKenzie Lowe.
The 12-year-old girl was diagnosed with an inoperable brain tumor a year ago.
Her family wants to use a drug called antineoplastons, which was developed by a controversial Texas physician.
The FDA classifies it as an investigational new drug, meaning is it not available for mainstream use.
Ayotte is among the 42,000 people who have signed an online petition asking the FDA to make a compassionate use exception.
In her letter, Ayotte says the family deserves the right to explore treatment options that may help McKenzie fight her cancer.
According to the family, the FDA has already made several hundred such exemptions for the drug.